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In nature filamentous fungi and bacteria compete for space and nutrients. Both kinds of
organisms have evolved mechanisms such as synthesis of antibiotic secondary metabolites
to defeat other microbes. Studies of synthesis of antibiotics and microbial ecology in
general have important applications in both agriculture and medicine. This thesis deals with
molecular responses in the filamentous fungus Aspergillus  nidulans to inhibitors of
V-ATPases, bafilomycin and concanamycin. These antibiotics are produced by various
species within the bacterial genus Streptomyces. The main function of V-ATPases in fungi
is to keep the vacuoles acidified. Inhibition of V-ATPases leads to fungal hyperbranching
and extremely reduced radial growth. Changes at the molecular level were observed when
the fungus was treated with the antibiotics. Using mRNA differential display, five genes
with changed expression after treatment were identified. A proteomic approach was used to
screen for affected proteins, and 20 proteins displayed changed abundance after antibiotic
treatment. Five of these were successfully identified. Most of these gene products were
previously unknown, but one could be directly linked to disrupted V-ATPases. The function
of several others could not, at this point, be directly related to inhibited V-ATPases. In this
thesis, two genes were further characterised. The first of them, vmaA, encodes a major
subunit of the V-ATPase. Disruption of vmaA confirmed that the V-ATPase is the main
target for bafilomycin and concanamycin in A. nidulans. This mutant strain promises to be a
useful tool in further studies of the identified gene products.  The most extensively studied
gene in this work is phiA. This gene was identified by mRNA differential display, and was
up-regulated by bafilomycin. Surprisingly, phiA  was found to be essential for normal
asexual development. This is intriguing, and several hypotheses can be formulated, of
which the most likely is that the induced phiA expression after inhibited V-ATPases is due
to secondary effects in the fungus, i.e. caused by triggering growth arrest. In this thesis,
several molecular methods, e.g.  differential display, proteomics, and immunohisto-
chemistry, have been used successfully to study interactions between bacteria and
filamentous fungi.
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Aim of the study
The main goal of this thesis was to study interactions between filamentous fungi
and bacteria at the molecular level. We chose to study responses at the molecular
level in the filamentous fungus Aspergillus  nidulans when it is treated with
bafilomycin and concanamycin. These two antibiotics are produced by several
Streptomyces species and function as specific inhibitors of V-ATPases that reduce
growth and alter the morphology of filamentous fungi. The more specific objective
of this work was to identify gene products in the fungus involved in the response
to these antibiotic secondary metabolites. A further objective was to compare
available techniques in molecular biology that may be useful in studies of
microbial interactions.
Introduction
Fungi and bacteria in the ecosystems
Fungi and bacteria frequently occupy similar niches
Filamentous fungi and bacteria often co-exist in a multitude of habitats, e.g. soil,
plants and litter. Competition for nutrients and space is frequently observed among
and between the two types of organisms. All fungi are heterotrophic organisms,
i.e. require uptake of organic carbon sources. If the nutrient source is depleted
most fungi can form one or several variants of spores, e.g. sexual spores in all
major fungal groups. Fungi can also form one or two kinds of asexual spores like
conidia, sporangiespores and chlamydospores. Several bacterial species also
produce spores, e.g. in the genera of Streptomyces and Bacillus. The spores can
survive in many different environmental conditions and can be dispersed over long
distances. In the competition between microbes, e.g. fungi versus bacteria, several
secondary metabolites have been evolved and produced to kill or stop growth and
dispersal of other hostile microbes (Maplestone et al., 1992).
Synthesis of secondary metabolites
Most studies concerning the competition between different microbes have been
aimed at elucidating the synthesis of antibiotic secondary metabolites. The
predominant hypothesis is that these secondary metabolites are synthesised to give
the producing organism a competitive advantage by killing or inhibiting growth of
other microbes. Alternative hypothesises have been proposed, e.g. the reduction of
abnormally high concentrations of intermediate metabolites during growth arrest.
One argument states that the concentrations of secondary metabolites in the field
are not high enough to stop growth of other microbes (Gottlieb, 1976; Brian,
1949). One strong reason why synthesis of these antibiotics is strictly related to the
competitive advantage is that the genes encoding a specific antibiotic together with
a resistance gene against it usually are located in the same gene cluster (Stone and
Williams, 1992). More research is required to understand the ecological and8
evolutionary aspects of secondary metabolites. There are also several important
applications in both medicine and agriculture connected with the competition
between microbes and the synthesis of secondary metabolites.
Using bacterial strains in biocontrol of filamentous fungi
Agriculture continually faces serious problem with fungal infections. Several fungi
produce a wide spectrum of mycotoxins that contaminates food. Many fungi are
plant pathogenic, e.g. Botrytis,  Fusarium and Magnaporte  whereas others
preferentially infect the food during storage, e.g. Penicillium and Aspergillus
(Samson et al., 2000). Since bacteria and filamentous fungi compete for space and
nutrients, e.g. by producing substances to mutually combat each other, it is
possible to use bacterial strains for biocontrol against fungi. The two most
commonly used bacterial genera in biocontrol are Bacillus and Pseudomonas
(Whipps, 2001). The use of fungal antagonistic bacteria in biocontrol has already
become quite common and serves as an alternative or a complement to the use of
pesticides. Naturally, there are biological, practical and legal problems associated
with biocontrol (Gerhardson, 2002). However, this thesis will exclusively address
problems connected with biology. Most importantly, since the bacteria probably
will secrete toxic compounds to defeat the fungus, these substances should be
harmless to mammals when used in biocontrol. Alternatively, toxins may be
unstable and thus be degraded before consumption. The efficiency of the potential
use of a biocontrol strain must also be measured both in terms of reduced fungal
growth and reduction of toxic compounds. Since stress can trigger fungi to, in turn,
produce toxic secondary metabolites, a reduced fungal growth does not necessarily
result in a less toxic food product.
Aspergillus nidulans, the model organism
The Euascomycete Emericella nidulans (Eidam) Vuill., more often known by its
anamorphic name Aspergillus nidudans (Eidam) Wint., has been used as a genetic
model organism for over 60 years. Most of the pioneering research outlined below
has previously been reviewed (Pontecorvo et al., 1953; Timberlake and Marshall,
1988; Timberlake, 1990; Martinelli and Kinghorn, 1994).
Several properties of A. nidulans make it a suitable model organism for studies
of the genetics in fungi or other eukaryotes. One main advantage is the simplicity
of culturing A. nidulans, and its ability to grow both as haploid and diploid. Strains
of A. nidulans can be maintained by vegetative growth or by inoculating conidia,
the asexual spores in Ascomycetes. The genetic regulation of asexual sporulation
in A. nidulans has been studied in far more detail than in any other filamentous
fungi (reviewed in Adams et al., 1998). Hundreds of conidia are produced from a
single Aspergillus  conidiophore, the typical spore-containing structure of all
Aspergilli species (Fig. 1). Several Aspergillus species, including A. nidulans, also
have a teleomorph (e.g. Emericella) that produces ascospores. Unlike some other
Aspergillus, species within the genus Emericella  do not form specific sexual
organs. A. nidulans is homothallic (has only one mating type), and can therefore
initiate sexual development by itself, whereas Emericella  heterothallica, by9
contrast, has two mating types. It has been reported that A. nidulans strains prefer
to mate with distantly related strains rather than with itself, a phenomenon called
relative heterothallism (Hoffmann et al., 2001). Sexual development is initiated by
fusion of two hyphal compartments, whereupon two haploid nuclei can fuse to
form a diploid nucleus. This diploid nucleus gives rise to one ascus containing
eight haploid ascospores. Hundreds of asci are formed in a larger, closed fruitbody
called a cleistothecium. Each cleistothecium is derived from a single hyphal fusion
and each ascus is derived from a single nuclear fusion event.
Figure 1. The conidiophore of A. nidulans. In contrast to some other Aspergillus species,
A. nidulans is biseriate, i.e., carries an extra cell layer, the metulae, which separates the
vesicle from the flask-shaped phialide cell.
In A. nidulans a great number of mutant strains have been isolated. Most of these
are auxotrophic for one or more amino acid(s), vitamin or nucleotide, e.g. arginine,
biotin or uracil. I.e., the fungus is unable to synthesise the substance in question,
and growth in a minimal medium therefore requires the nutrient to be
supplemented. There are also strains with mutations that result in morphological
phenotypes such as reduced growth or a colour different from that of the normally
green conidia. These mutations are useful as genetic markers and are ideal for
selecting or crossing different strains. Another beneficial property of A. nidulans is
its ploidity: the fungus is normally haploid, but diploid strains can easily be
produced and maintained. To create a diploid strain mycelium of two strains with
different selective markers are fused to create a heterokaryon (a strain with nuclei
from at least two different genotypes). Spores from two strains are mixed and
germinated in non-selective medium and then transferred to selective medium.
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Stable heterokaryons will grow rapidly and are therefore easily isolated.
Diploidisation of nuclei occurs spontaneously at a very low frequency (one
nucleus in a thousand is diploid). Thus, single conidia can be transferred to
selective media on which only heterozygous diploids can germinate. Diploid
strains will degenerate spontaneously on non-selective media. A diploid A.
nidulans  strain can be treated with benomyl, a substance that induces
haploidisation. Subsequently, haploid strains can be selected by their faster
growth. It must be emphasised that this diploidity is different from the one prior to
ascospore formation since in diploid strains all nuclei are diploid. These strains
undergoes sexual development but at a lower frequency, and each ascus contains
16 haploid ascospores. The complete lifecycle of A. nidulans is shown in Figure 2.
The features mentioned above make A. nidulans a very useful tool in classical
genetics. In modern molecular biology, it is also essential to manipulate the DNA
molecule, which is feasible in A. nidulans. Foreign DNA can be integrated by
heterologous recombination (the DNA is integrated in the genome at a non-
specific site). This is an important tool for studies of gene function in A. nidulans
or for expression of heterologous proteins (Timberlake and Marshall, 1989).
Disruption of a specific gene can be performed in A. nidulans using homologuos
recombination.  E.g., a mutated gene recombines with the wild-type gene and
disrupts its function. Transformation of fungi is usually performed using an
auxotrophic strain (Ballance et al., 1983; Tilburn et al., 1983; Yelton et al., 1984),
e.g. auxotrophic for arginine. Such as strain carries a deleted or mutated argB
gene, and is transformed with DNA containing an intact argB gene to create
arginine prototrophs (strains that can grow without addition of arginine into the
medium). There is also a possibility to transform DNA with a gene that codes for
resistance to a specific antibiotic, e.g. hygromycin B. Transformants can then be
selected on plates containing the antibiotic (Punt et al., 1987; Cullen et al., 1987).
However, this method has not been frequently used in A. nidulans since several
suitable nutritional markers are available; the use of nutritional markers is
generally more effective and much less expensive than the use of antibiotics.
The A. nidulans genome contains approximately 39 million base pairs (Kupfer et
al., 1997). This is approximately three times the size of the yeast genome but only
about 1 % of the human genome. The genomes of A. nidulans and other fungi have
only short regions of repetitive (or junk) DNA that make them suitable as model
organisms within the eukaryotic domain. The estimated number of genes is 8000
(10-25 % compared to the current estimates of the number of genes in humans).
The entire sequence of the A. nidulans genome has recently been determined by
Cereon Genomics, and is now, with some restrictions, available to the research
community. Although there are several reasons to choose A. nidulans as the model
organism in this study, one alternative species, the heterothallic Euascomycete
Neurospora crassa, was also considered. Both fungi have similar features but with
advantages and drawbacks. The reason for choosing A. nidulans for the present
study was that it is a close relative to other, more economically or medically
important fungi, within the genera of Aspergillus, e.g. A. flavus, A. fumigatus and
A. oryzae.11
Figure2. The life cycle of Aspergillus  nidulans. During the asexual cycle the fungus
propagates with conidia. In the sexual cycle ascospores are formed in large fruit bodies
(cleistothecia). In the parasexual cycle, including formation of diploids, genetic
recombination occurs without meiosis.12
Antibiotic secondary metabolites produced by bacteria
Streptomyces sp.
Most antibiotics known today are produced by bacteria within the genus
Streptomyces  (Demain, 1999). The Streptomyces, similar to filamentous fungi,
form long filaments, and produce spores and a large variety of secondary
metabolites. Streptomyces  species and many filamentous fungi occupy similar
ecological niches. Therefore, it can be expected that production of, and defence
systems against, hostile secondary metabolites have evolved during competition
between these two types of organisms. These filamentous bacteria are oligotrophic
gram-positive bacteria usually habituating soil (Hodgson, 2000). Most antibiotic
compounds produced by Streptomyces are associated with sporulation (Bennett,
1995). In May 2002, the complete genome of Streptomyces coelicolor  was
published (Bentley et al., 2002). This genetic information will facilitate studies in
the areas of antibiotic synthesis and Streptomyces biology in general.
Antifungal substances and their targets
Since fungi are eukaryotes, most of the antibiotics effective against fungi are also
toxic for animals, including man. There are, however, some unique features in the
fungal kingdom, e.g. the chitin-containing cell wall that might provide fungus-
specific targets. Antibiotic compounds that target the fungal cell wall may be
useful in treatment of fungal infections (Hector, 1993). Chitin synthases are
inhibited by polyoxins and nikkomycins, both produced by various Streptomyces
species (Li and Rinaldi, 1999). Another predominantly fungal substance is
ergosterol, a sterol located in the cell membrane (Bowman et al., 1987). The most
commonly used antifungal component in medical treatments is amphotericin B, a
Streptomyces-produced polyene. This antibiotic forms a complex with ergosterol
that causes leaking of the membrane. Unfortunately, amphotericin B is
nephrotoxic and its usage is therefore limited (Finquelievich et al., 2000). Today,
the improved methods used to treat immunosuppressed patients, i.e. in patients
with cancer or HIV, have accentuated the problem of fungal infections. Therefore,
there exists an urgent need to discover new antifungal compounds, and to develop
new treatments.
The fungal vacuole
Form and function of fungal vacuoles
Vacuoles of filamentous fungi vary greatly in form and size. They can be both
spherical and tubular (Weber et al., 1999) whereas yeasts usually contain only one
single large vacuole (Banta et al., 1988). The fungal vacuole has its counterpart in
plants (the plant vacuole) and in animals (the lysosome) but differs from these in
both form and function. The functions of fungal vacuoles are many: storage of
nutrients, digestion of organelles and polypeptides, and regulation of the
concentrations of several ions (Klionsky et al., 1990). Adjacent vacuoles are
connected and involved in transport and allocation of nutrients throughout the13
mycelium (Weber, 2002). The pH in the vacuoles is around six, and is regulated by
the vacuolar ATPases that pump protons into the vacuole.
Vacuolar ATPases and its inhibitors, bafilomycins and concanamycins
The vacuolar ATPase (=V-type ATPase or V-ATPase) is present in all eukaryotes.
It acidifies various organelles, e.g. endosomes and lysosomes in animals and
vacuoles in fungi and plants (Forgac, 1989). Intensive research is currently carried
out to study the form and the many functions of the V-ATPases. This is of great
medical interest since this enzyme is proposed to have a role in tumour metastasis,
entry of viruses such as HIV and mutations in V-ATPases can also cause deafness,
(reviewed in Nishi and Forgac, 2002). In fungi the enzyme's main function is to
keep the vacuole acidified, but additional functions may relate to various other
cellular processes. In N. crassa and Saccharomyces cerevisiae the V-ATPases are
composed of 13 different subunits (Margolles-Clark et al., 1999; Stevens and
Forgac, 1997; Fig. 3).
Figure 3. The V-ATPase. The enzyme consists of one cytoplasmic domain, subunits A to H
and one transmembranic domain, subunits a, c and d,  (adapted from Nishi and Forgac,
2002).14
The use of specific inhibitors of the proton pumps aids in the elucidation of the
architecture and functions of the V-ATPases. The two most potent specific
inhibitors of V-ATPases are the bafilomycins and the concanamycins (Fig. 4).
Bafilomycin (A-D) and concanamycin (A-F) belong to a class of macrolide
antibiotics produced by several Streptomyces species (Dröse and Altendorf, 1997).
Bafilomycin B is also known as setamycin (Omura, 1986), and concanamycin A as
folimycin (Muroi et al., 1993). The chemical structures of bafilomycin B1 and
concanamycin A are shown in Figure 3. When filamentous fungi, e.g. Penicillium,
Aspergillus and Neurospora,  are treated with these antibiotics both growth
inhibition and morphology changes are observed. The mycelium is hyperbranching
and more swollen than in untreated fungi (Bowman et al., 1997; Frändberg et al.,
2000). Neurospora strains with a disrupted V-ATPase subunit A also show this
hyperbranching characteristic. These mutant strains are also totally resistant to
concanamycin A, suggesting that the V-ATPase is the only target for the
antibiotics (Bowman et al., 2000). One hypothesis suggests that the increased
branching occurs because the fungus with disrupted V-ATPases cannot control the
Ca
2+  concentration in the cytoplasm. It is well known that calcium plays an
important role in the regulation of hyphal tip growth (Heath, 1995; Regalado,
1998).
Figure 4. The chemical structures of  (a) concanamycin A and (b) bafilomycin B1, the two
V-ATPase inhibiting antibiotics used in this study.
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How can we study the interactions between bacteria and
filamentous fungi at the molecular level?
Relatively few studies of interactions between different kinds of microbes have
been conducted at the molecular level. There are several methods available that
may be useful in such studies. I chose here to distinguish between quantitative and
qualitative approaches. Quantitative studies aim at monitoring gradual changes in
gene expression and protein synthesis. This can be done both for specific genes
/proteins or by screening for gene products that increases or decreases after
encountering other microbes. Qualitative studies focus on the function of specific
genes or proteins. Alternatively, these studies can be used to screen for and to
identify genes that have a specific function. Figure 5 summarizes most of the
described approaches in relation to the central dogma of molecular biology.
Quantitative approaches
These kinds of methods measure the relative amount of mRNAs, proteins or
metabolites present in an organism, comparing at least two different conditions. In
the organism the protein is usually the functional gene product, e.g. serving as an
enzyme, but regulation occurs mostly at the transcriptional level (Lewin, 2000).
Disregarding post-transcriptional control, measurements of mRNA synthesis give
a good indication of the amount of protein synthesised. Small RNAs may also be
active as regulatory components, i.e. by antisense mechanisms (reviewed in
Wagner and Flärdh, 2002). However, in filamentous fungi no proof of natural
antisense systems has to my knowledge so far been described.
Comparing the expression of a single gene under different environmental
conditions
Depending on the changes in the environment, the expression of a gene may vary.
Typically, a gene encoding a stress-induced protein is expressed under a condition
of environmental stress. The standard method to measure such expression
differences is using Northern blots. If the transcript is very rare it is possible to
enhance detection by reverse transcription of the mRNA into cDNA, followed by
quantitative RT-PCR (QRT-PCR; reviewed in Freeman et al., 1999). Using a
PhosphorImager it is easy to quantify differences in gene expression measured by
Northern blot analysis or QRT-PCR. Differences in abundance at the protein level
can be detected using Western blots.
The above methods do not explain the mechanisms behind the changed
expression. Using a construct containing the promoter of the fungal gene of
interest upstream of a reporter gene such as the Escerichia  coli lacZ gene it is
possible to easily detect changes at the transcription level (van Gorcom et al.,
1985). This method is also suitable to map promoters or other regulatory regions
that are essential for the change in expression, i.e. binding sites for a transcription
factor. This approach has been successfully employed in studies of Aspergillus
development  (Adams and Timberlake, 1990; Han and Adams, 2001) and
penicillium synthesis (Brakhage and Brulle, 1995).16
Differential screening
Differential screening has been used in filamentous fungi to screen for genes that
are involved in the formation of asexual spores (Boylan et al., 1987). A genomic
library is dot-blotted onto, e.g. a nitrocellulose filter. Labelled cDNA from two
different environmental or physiological conditions, e.g. vegetative growth and
developed hyphae, are then hybridised to the filter. If a single dot only hybridises
with cDNA from sporulating fungus it may contain a gene responsible for
sporulation. The main problem with this approach is that in order to be able to
screen the entire genome, the cosmids have to be numerous or very large. This
approach tends to be very labour-intensive if a gene of interest is to be identified.
With A. nidulans it is possible to purchase gene libraries separated in up to 38
chromosome-specific 96-well microtiter plates that may facilitate the screening
process (Brody et al., 1991). Another drawback with differential screening is that,
similar to all RNA-based methods, this approach does not account for any post-
transcriptional modifications. Also, due to the detection limits, low abundance
transcripts will not be detected in any of the cDNA pools. Many variants of this
approach have been described. The most sophisticated variant is, in my opinion,
the microarray technique that will be described further below.
mRNA differential display
Since differential screening is time-consuming, several techniques have been
developed to simplify detection of mRNA that is differentially expressed under
different conditions. mRNA differential display (RNA-DD; Liang and Pardee,
1992) is based on the principle that two or more pools of RNA are reverse
transcribed with primers that hybridise to the poly A tail of mRNAs (usually 12
thymidine bases and one or two additional bases at the 3´end which may be
degenerated , e.g. T12MA, a primer consisting of 12 thymidine bases, followed by
a G, A or C and a final A at the 3’ end). The obtained pools of cDNAs are then
used as templates for PCR. Short, usually decameric, arbitrary primers  (AP) and
the T12MN primers are used in this amplification. PCR products are subsequently
separated on sequencing gels, and are visualised by autoradiography or silver
staining. DNA fragments present exclusively, or more abundant, in lanes
corresponding to one of the treatments, represent candidate genes that may in some
way be involved in the response. RNA-DD has been used successfully with fungi,
e.g. in Gibberella to monitor genes involved in synthesis of secondary metabolites
(Appleyard et al., 1995).
The main problem with RNA-DD is the great number of false positives often
found using this technique. Even if duplicate and independent reverse
transcriptions and PCR are performed, the majority of bands may represent false
positives (Liang and Pardee, 1995). To confirm that the bands correspond to
differentially expressed genes the relative change in expression has to be measured
using Northern blots or QRT-PCR. The latter method is to prefer only if working
with small amounts of RNA. To reduce the high frequency of false positives
inherent in RNA-DD several similar methods have been developed, reviewed in
(Matz and Lukyanov, 1998). Finally, RNA-DD only provides sequence
information about a region close to the poly-A tail. In order to identify the entire
gene the sequences can be blasted against published protein, cDNA, or genomic17
databases, if available. If both the gene and the genome are unknown, the
corresponding full-length mRNA sequence may be obtained using 5’ RACE
(Frohman et al., 1988). Alternatively, the encoding DNA can be deduced using
one of several PCR strategies that detect flanking DNA, i.e. inverse PCR (Ochman
et al., 1988) and step-down PCR (Zhang and Gurr, 2000).
Microarrays
Today, as entire genome sequences and expressed sequences for more and more
species have been published it is possible to screen for, in principal, all
differentially expressed genes in a single experiment. The main principle of
microarrays is to attach up to several thousands nucleic acid sequences
corresponding to different transcripts on a glass plate; whole cDNAs or
oligonucleotide arrays corresponding to a single gene can be used to represent
each transcript. A convenient way to screen for differentially expressed genes is to
generate two cDNA pools generated from RNA of the organism, grown under the
two different environmental conditions of interest. The cDNAs are labelled, each
with a different fluorescent dye. The two pools of cDNA are then hybridised
simultaneously to the glass plate. If the expression of a gene is higher in one
condition than in the other, this is scored as an increase in the ratio of the dye-
specific signals (Brown and Botstein, 1999; Duggan et al., 1999).
Naturally, there are limitations of this method. Most of the drawbacks of the
RNA-DD technique are also evident when using microarrays. Generally,
micoarrays require greater amounts of total RNA than RNA-DD. Despite this, and
the high initial costs required to produce the glass plates, microarray is a very
promising technique and it will certainly be used more frequently when studying
microbial interactions. As an example, it has been used in Candida albicans to
detect genes whose expression was changed upon treatment of the fungus with
itraconazole, an antifungal compound that stops the synthesis of ergosterol (De
Backer et al., 2001).
Proteomics
Differential screening, mRNA differential display and microarrays only measure
changes at the mRNA level. However, even if the amount of a specific mRNA has
changed one cannot be certain whether this mirrors a proportional change in the
abundance of the encoded protein. Likewise, different splicing patterns of the
transcript cannot easily be detected with these screening methods.
By using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) a
significant part of the whole proteome can be displayed. Total proteins (from two
or more conditions/cell types etc) are first separated in one dimension according to
their iso-electric points. The gel with iso-electrically separated proteins is then
transferred to an SDS-polyacrylamide gel, and the proteins are subsequently
separated according to their size (second dimension). Proteins are visualised by
autoradiography or staining (silver or Coomassie blue). Dependent on gel
conditions, different parts of the proteome can be displayed. Protein spots of
changed abundance under one set of conditions are likely to be directly or
indirectly involved in the response to the new environment. However, it is18
essential to pay attention to reproducibility since the gels and the detection
methods are occasionally not perfectly matched between runs. There is computer
software available to match and quantify proteins spots on series of proteomic
gels. The next step is the identification of the protein. For several organisms,
available proteomic databases facilitate the identification of the protein analysed.
When working with an organism for which no such database has yet been
established, or if the protein spot of interest has not previously been annotated, the
protein spot must be extracted from the gel and identified. Several methods have
been developed for determination of amino acid sequences (Hunkapiller et al.,
1984).  The fastest and most sensitive way to identify the proteins is Mass
Spectrometry (MS). Nanomolar amounts of proteins are digested, and the
sequences of the resulting shorter peptides are derived by measuring their
molecular masses, followed by calculations based on the known masses of amino
acids (Wilm et al., 1996).
Proteomics is a rapid and convenient method to screen for proteins involved in a
certain response. The potential problem using 2D-PAGE lies in the identification
of previously unknown proteins. If working with an organism for which a large set
of Expressed Sequence Tags (EST) has been obtained, the full-length protein can
be deduced by blasting the peptides against the EST database. Similarly, a
genomic sequence database can be employed. However, the presence of introns in
eukaryotic mRNAs occasionally renders this problematic. The sequenced peptides
may be encoded, in part, by different exons, and therefore the matching score may
not be high enough to identify the encoding DNA sequence. If the sequence of an
organism in question, or that of a very closely related one, is not available, the
sequence of the entire protein can be obtained using methods like Edman
degradation. Alternatively, degenerated primers can be designed from the peptide
sequences. These primers can then be used in PCR or for hybridisation in order to
find the encoding DNA sequence. All of these approaches are time-consuming.
Therefore,  proteomics is not recommended unless EST or entire genomic
sequences are available. So far, this approach has been used successfully in
A. fumigatus and Trichoderma reseei for the identification of cell wall proteins
(Bruneau et al., 2001; Lim et al., 2001).19
Metabolomics
The last of the quantitative methods described here is metabolomics. In this case,
gene products are not detected, but rather the compounds produced by them. The
term metabolome denotes the sum of all metabolites present in and around an
organism. The total number or metabolites is usually much lower than the number
of different proteins and mRNAs in an organism. E.g., in S. cerevisiae it has been
reported that the entire metabolome consists of only ≈600 metabolites (Oliver et
al., 1998). It is likely that the pattern of metabolites produced by one organism is
changed when it encounters a second one. Both the synthesis of primary and
secondary metabolites may be affected. Changes in the metabolome can be
detected by analytical methods such as Nuclear Magnetic Resonance (NMR),
Mass Spectrometry (MS) or Liquid Cromatography-Mass Spectrometry (LC-MS).
Multivariate statistics is generally required for data analysis (Raamsdonk et al.,
2001). The information obtained from a metabolomic study can be useful by itself,
but a combination with other approaches, e.g. proteomics or microarrays, may be
more instructive. With such a combined approach it should be possible to link
gene products to their metabolites, i.e. the enzymes involved in the synthesis of
specific metabolic compounds can be revealed.
Qualitative approaches
Overexpression of a specific gene and targeted gene disruption
None of the quantitative approaches mentioned above gives any direct information
about the function of the identified gene or protein. I.e., a RNA-DD approach may
have revealed a gene that is overexpressed in one microbe when encountering a
substance produced by another microbe. The objective is now to characterize the
function of this gene. This can be accomplished as follows. The gene is
overexpressed, and increased resistance against the substance is tested.
Overexpression can be triggered by constructing a plasmid with the gene of
interest fused with an inducible promoter, e.g. the alcA gene mentioned above
(Adams  et al., 1988),  after transformation into the organism. The opposite
approach uses mutations or complete gene deletions, scoring for a phenotype. A
convenient way to delete genes in an auxotrophic Aspergillus strain involves the
construction of a vector initially containing the intact gene with its flanking
regions. The plasmid-borne target gene is then replaced by a marker gene (a gene
that restores prototrophy for a nutrient). Finally, this construct, in linearized form,
is transformed into an auxotrophic strain (Fincham, 1989).
Random gene inactivation and overexpression
In order to find genes involved in resistance or sensitivity to another microbe or a
compound, one can randomly disrupt genes and subsequently screen the resulting
mutant strain against the organism/compound. One method involves the
introduction of mutations, e.g. by exposure to UV light, followed by a search for
resistant or hypersensitive strains. By transformation of the target organism with a
gene library, and screening for complementation of the target gene, followed by
retransformation of a complementing plasmid into E. coli cells, the gene encoding
the desired complementing activity can be sequenced and identified (Johnstone et20
al., 1985). By this method only point mutations are introduced. If a target gene
carries such a mutation, one may for instance observe that the antibiotic can no
longer interact with the gene product, which however may retain residual activity
required to fulfil its role.
Genes can also be inactivated using Restriction Enzyme-Mediated Integration
(REMI). Here, the organism is transformed with a mixture of a restriction enzyme
(e.g. BamHI) and a plasmid that has been linearized using the same enzyme. The
plasmid will integrate between two BamHIsites, randomly generated by cleavages
of chromosomal DNA, and may occasionally disrupt a gene. Mutant strain isolates
with desired traits carry the integrated plasmid flanked by the two segments of the
disrupted gene. By rescue (digestion of genomic DNA with a second enzyme,
ligated and retransformed into E. coli) the gene sequence can be obtained (Sanchez
et al., 1998; Schiestl and Petes, 1991). In A. nidulans, this strategy has been used
to screen for genes involved in multidrug resistance (de Souza et al., 2000). A
different approach giving similar results uses transposons, mobile DNA elements
that can jump into and thereby disrupt genes. This approach has been implemented
in fungi (reviewed in Kempken and Kuck, 1998). Both REMI- and transposon-
mediated mutagenesis are useful due to the simplicity of target gene recovery.
However, point mutations are not generated and, therefore, it is less likely that a
gene disruption may increase the resistance against a hostile compound.
Screening for mutated genes that result in phenotypes of interests can also be
performed by random overexpression of introduced genes. In Aspergillus, the alcA
promoter has been used for controlled overexpression of genes integrated
downstream; this promoter is activated by ethanol (Gwynne  et al., 1987). By
constructing a library of genes preceded by the alcA promoter it is possible to
screen for genes whose overexpression results in a phenotypic change (Marhoul
and Adams, 1995).
Localisation of proteins or mRNAs of interests
The putative function of a gene product can also be approached by determination
of its intracellular location. Probes can be used to detect in which hyphal
compartments an mRNA is synthesized, or where a protein is located. mRNA can
be visualised using radioactive or fluorescent probes that bind to the RNA.
Proteins can be detected using immunohistochemistry. Polyclonal or monoclonal
antibodies are raised against a specific protein. Secondary antibodies with
fluorescent, radioactive, enzymatic or heavy metal markers can then be used to
detect the protein-antibody complex. The choice of marker is dependent on the
microscopic system used. An alternative localization method is based on hybrid
proteins. A DNA construct, that encodes a fusion between the target protein and a
marker protein, is transformed into the organism. The introduced protein can be a
target for monoclonal antibodies or be fluorescent by itself. The green fluorescent
protein (GFP) from jellyfish is often used for such fusion experiments. The use of
a plant-adapted GFP has been successful in Aspergillus (Fernandez-Abalos et al.,
1998).21
Figure 5.  A graphical overview of methods discussed in this thesis. Left hand figures
shows the central dogma; DNA-RNA-Protein. Right hand: Methods indicated by bold
characters are illustrated.22
Present investigation
mRNA differential display and proteomics to display genes   and
proteins involved in response to Streptomyces-produced
V-ATPase inhibitors (I,II)
Previously, in a search for fungal antagonistic bacteria with a potential use in
biocontrol of filamentous fungi, a Streptomyces halstedii strain was isolated. This
strain produces substances that reduce growth and increase the branching of
filamentous fungi (Frändberg and Schnürer, 1998). These substances were
identified as bafilomycin B1 and bafilomycin C1 (Frändberg et al., 2000).  The
bafilomycins, and the similar concanamycins, are known as inhibitors of
V-ATPases, but other targets may exist. We were interested in responses, at the
molecular level, in the fungus, and wished to investigate whether other targets of
the antibiotics could be identified. To answer these questions we chose to use the
well-characterized filamentous fungus A. nidulans as a model organism. Figure 6
shows the morphology of A. nidulans treated with bafilomycin.
Figure 6. Bafilomycin changes the growth rate and morphology of A. nidulans.
(a). Untreated A. nidulans. (b). A. nidulans treated with bafilomycin B1 (25 µg/ml).
(a) (b)23
Mimicking the fungal-bacterial interaction
Instead of using a system consisting of both bacterium and fungus we decided to
simplify the system by growing the fungus in the presence of the antibiotic. To
grow the fungus we inoculated conidia from A. nidulans in liquid media for 48
hours. Since the antibiotics severely inhibited spore germination, the compounds
were added into medium after 24 hours of growth. No sporulation occurred in this
submerged system. This observation may be of importance, since several gene
products in A. nidulans are associated with sporulation. Removal of these gene
products from the system probably resulted in a less complex transcriptome and
proteome.
mRNA differential display
In the first study (I), we prepared total RNA from A.  nidulans grown in the
presence of bafilomycin B1. By RNA-DD, using 20 different primer combinations,
a total of 20 bands, corresponding to putative target genes, were excised from the
gels. After confirmation by QRT-PCR with sequence specific primers, five genes
were unambiguously scored as being differentially expressed. Next, 5´ RACE was
used to obtain full-length cDNA for each of the five genes.
Proteome analysis
In this study (II) we prepared proteins from A. nidulans grown in the presence of
concanamycin A in Yeast Nitrogen base. The change from the non-specific malt
extract to the more specific Yeast Nitrogen base was motivated by our desire to
limit carbon and nitrogen sources to glucose and ammonium acetate only, and thus
to repress as many proteins as possible. Another objective for this proteomic
approach was to compare two different screening methods, RNA-DD at the
transcription level, and 2D-PAGE at the protein level. In the first dimension,
proteins were separated according to their pI values in the range from 3 to 10. In
the second dimension we used both 10 and 15% PAGE in order to resolve as many
proteins as possible. 
14C-labelled amino acids were added simultaneously with the
antibiotic, in order to permit subsequent assessment of proteins synthesized. This
procedure enabled monitoring of only the proteins synthesised subsequent to
concanamycin treatment. In parallel, we also silver-stained some pairs of gels, to
confirm reproducibility, and to facilitate excision of unlabelled protein spots for
MS identification. Of a total of twenty proteins with changed abundance after
treatment, six proteins were extracted and digested with trypsin, followed by MS
analysis. For five of these we could deduce, by blasting against several databases,
the entire amino acid sequence of the protein.24
Summary of genes and proteins found
In the following, the identities of the discovered genes and proteins are discussed
briefly. More information can be found in the included papers. However, I have
obtained additional results regarding breB that were not available at the time of
publication. bre  stands for bafilomycin repressed gene, bin  for bafilomycin
induced gene, Cip for concanamycin induced protein, and Crp for concanamycin
repressed protein.
breA, 20-fold down regulated  mRNA expression after bafilomycin B1 treatment.
This gene had been previously identified in A. nidulans as aspnd1. It encodes a
cell wall-associated protein involved in zinc uptake into the cytoplasm. Its
expression is triggered when the concentration of Zn
2+ decreases in the medium
(Segurado et al., 1999). Since disruptions in the V-ATPases in N. crassa and S.
cerevisisae are hypersensitive to zinc, this down-regulation of breA may protect
the organism from uptake of toxic Zn
2+ (Bachhawat et al., 1993; Bowman et al.,
2000; Eide et al., 1993; Ramsay and Gadd, 1997). Treatment with concanamycin
A resulted in an even higher decrease in expression, i.e. 100-fold.
breB, 10-fold down regulated  mRNA expression.
The encoding cDNA of this gene does not seem to contain an ORF. In the 1642
base pairs long fragment obtained, the longest identifiable ORF had a length of
414 bp and lacked a putative ATG start codon. Thus, an mRNA is transcribed but
an encoded protein-related function cannot be deduced. When I used
concanamycin in paper II, repression was more severe, i.e.  gave a 20-fold
reduction in mRNA synthesis. Examination of the DNA sequence indicated it to be
purine-rich and very repetitive. E.g., it contains two AGGCAGAAGAACGCCAG
repeats. By inverse PCR (Ochman et al., 1988), we found that the sequence 5’ of
the transcription start of breB shares 133 base pairs of 96% similarity with the 5’
region of a published teleomeric sequence consisting of TTAGGG repeats
(Bhattacharyya and Blackburn, 1997). The region of sequence similarity is located
entirely at the 5’ end of the two sequences.  The TTAGGG repeats is not included
in the breA gene. At this point, we cannot assess the significance of these results.
binA, 60-fold up regulated  mRNA expression.
The short mRNA encoded by binA contains an ORF, but neither the mRNA nor
the deduced protein indicate any described homologies to proteins, or conserved
motifs.
binB, 30-fold up regulated  mRNA expression.
This gene is found in all filamentous Euascomycetes, of which abundant sequence
information is available. This suggests that the encoded protein is conserved
among this group. At the protein level, I found similarity to a stress-induced gene
in S. cerevisise (van der Vaart et al., 1995). Since this similarity is limited to the
N-terminal halves of these proteins, they may not be, strictly speaking,
homologues (in this region, approximately 50 % of the amino acids are identical or
exchangeable). This gene is further characterised in (IV) under its new name phiA.25
binC, expression was only observed after treatment with bafilomycin.
The deduced amino acid sequence encoded by this gene suggests a short cysteine-
rich, mostly hydrophobic protein. Despite these features, this protein does not
fulfil the requirements of a hydrophobin (Wessels, 1996). Expression of binC was
only detected after treatment with bafilomycin B1. When changing the growth
conditions and the antibiotic to concanamycin, no expression was observed under
any conditions.
CipA, up-regulated 2-fold.
This protein is homologous to a hypothetical protein in Candida whose expression
is strongly up-regulated by cadmium (Hong et al., 1998). It is also homologous to
plant proteins involved in the synthesis of phytoalexins (Kuc and Rush, 1985).
This similarity to a plant defence system is intriguing but may also be coincidental.
CipB, up-regulated up to 50-fold.
The abundance of this protein on 2D gels was variable. In some experiments, it
was scored as very abundant on both treated and in treated gels, and sometimes it
was present only in negligible amounts. However, in most pairs of proteomic gels
the protein was almost only present after concanamycin treatment. In these cases it
was perhaps the most abundant protein in the displayed proteome. CipB is
homologous to LovC, a protein identified in Aspergillus terreus, which is incolved
in the synthesis of lovastatin (Kennedy et al., 1999), a secondary metabolite
working as a cholesterol-decreasing agent (Alberts et al., 1980). The ambiguous
abundance of CipB may be due to the fact that it is only synthesised in the fungus
after growth arrest. Concanamycin may, in some samples, have triggered growth
arrest at an earlier time point.
CipC, up-regulated 6-fold
This protein was previously unknown, except for a homologue represented by an
mRNA sequence in Aspergillus niger.
CrpA, down-regulated, 3-fold
The first of the down-regulated proteins had previously been identified as the A.
nidulans CpcB, a Gβ-like protein involved in global amino acid control and
initiation of sexual development (Hoffmann et al., 2000).
CrpB, down-regulated 2-fold
The corresponding gene for this protein has previously been identified as gpdA,
and encodes glyceraldehyde-3-phosphate dehydrogenase, a central protein in
glycolysis (Punt et al., 1988). The overall reduced growth rate may explain the
decreased abundance of GpdA after treatment with concanamycin.26
Remarks
In the proteomic study (II) an additional 15 proteins displayed changed abundance
after treatment. We tried unsuccessfully to identify one other protein (CipD) using
MS but we could not deduce the corresponding DNA sequences from the obtained
peptide sequences. The remaining 14 protein spots were not further investigated,
since their intensity indicated that identification by MS would be cumbersome.
From the analysis presented, it is clear that overlap between genes/proteins
identified in the two studies (I, II) was not found. It remains however possible that
such overlaps may be present within the remaining set of 14 proteins.
At this point, few conclusions can be drawn about the identified gene products.
The genes and proteins discussed above fall into three different categories;
(i). Known genes or proteins with a function that can be related to inhibited
V-ATPases, i.e. breA and, possibly, CrpB. (ii). Gene products that have previously
been described, or have known homologues, but lack obvious connection to
inhibited V-ATP. Perhaps the binB gene, and most certainly two of the identified
proteins (CipA and CipB), may be correlated to physiological stress situations.
(iii). Totally unknown gene products.
Disruption of the V-ATPase subunit A in Aspergillus nidulans
(III)
In this work we decided to disrupt the gene encoding subunit A of the V-ATPase
of A. nidulans. It had previously been shown in N. crassa that the V-ATPase is the
main target of concanamycin (Bowman  et al., 2000). The morphology effect
obtained after treatment of A. nidulans is however more severe, suggesting that the
antibiotic affects the two filamentous fungi differently, or at least to different
degrees. Another aim addressed by the disruption in A.  nidulans was the
construction of a strain that would be useful in further studies of the genes and
proteins identified in papers I and II. Since most of these gene products were
totally or mostly unknown it was of interest to investigate whether there were
direct connections between the inhibited V-ATPases caused by bafilomycin and
concanamycin, or whether changes were more indirectly linked. One of the
previously identified genes, breA (expression down-regulated by bafilomycin),
was previously identified in A. nidulans as aspnd1, encoding a zinc binding
protein (Segurado et al., 1999). Since Zn
2+ is reported to be toxic in other fungi
(Bachhawat et al., 1993; Bowman et al., 2000; Eide et al., 1993; Ramsay and
Gadd, 1997), we wanted to investigate if this also holds true in A. nidulans. If so,
this would link the reduced expression of breA to a mechanism that prevents
undesired uptake of toxic Zn
2+.27
Growth, physiology and morphology of the vmaA1 mutant
The vmaA gene was disrupted by homologous recombination. The phenotype of
the mutant strain is characterized by extremely slow growth and increased
branching. This is reminiscent of the morphology in the fungus after treatment
with bafilomycin or concanamycin (Fig. 7). This suggests that the V-ATPase is the
only target for the antibiotics also in A. nidulans. The fungus grew at an extremely
low rate. Only occasionally any form of developed hyphae were observed, but
mature conidia were always lacking. From this severely affected mutant strain it
was difficult to extract nucleic acids. In order to grow and maintain the strain, we
had to harvest conidia from a heterokaryotic strain. In agreement with previous
studies in S. cerevisisae and N. crassa, the mutant strain was unable to grow at
basic pH and at high concentrations of Zn
2+.
Figure 7. Morphology of the vmaA1 mutant.  See Figure 6 for a comparison with wild-type
and bafilomycin-treated A. nidulans.28
Characterization of the phiA gene in Aspergillus nidulans (IV)
In the previous studies (papers I  and  II) we found several unknown genes or
proteins affected by bafilomycin and concanamycin. However, these studies
remain inconclusive until the gene products are characterised. I decided to
concentrate my efforts on one of the up-regulated genes, binB. The function of the
corresponding protein was unclear, but some sequence similarity with a stress-
induced protein in S. cerevisiae (van der Vaart et al., 1995) was observed. This is
intriguing since treatment of A. nidulans with bafilomycin should constitute a
stress for the fungus. However, only some sequence segments of the two proteins
are similar, and hence homologies cannot be unequivocally confirmed. Searching
several DNA and EST databases I found homologous proteins in other filamentous
Euacomycetes (>60 % amino acid identity or similarity). All filamentous fungi for
which abundant sequence data are available (genomic or EST), encode binB
homologues. Thus, even if this gene does not encode a general stress protein, it
may encode a protein unique in filamentous Euascomycetes. Incidentally, when
preparing paper I, we were not aware that the name bin already was used for a
class of A. nidulans genes (Hynes, 1975). During preparation of this paper, we
therefore renamed the gene to phiA, due to its presence and importance in phialide
development (see below).
Morphology of the phiA1 mutant
If one wants to elucidate the function of a gene, it is useful to create a deletion
mutant and monitor the resulting phenotype. This is only possible if the gene is not
vital for the fungus. The phiA gene was disrupted by homologous recombination.
An arginine auxotrophic strain was transformed with a plasmid in which part of
the cloned phiA gene had been replaced by the A. nidulans argB gene. Arginine
prototrophs were selected. Subsequent analysis showed that in some transformants
phiA had been disrupted. The phenotype of these mutants is slow growth and
reduced asexual development. Observation of the conidiophores revealed that the
phialides were not developed properly. In some conidiophores the phialide formed
a complete new hypha. Conidia were rare and occured sparsely, instead of in long
chains as in the wild type (Fig. 8).
The functional link between treatment with bafilomycin and normal
conidiophore development is not clear. It is possible that the PhiA protein carries
out multiple functions. It is also possible that dysfunctional V-ATPases indirectly
trigger sporulation and synthesis, and thereby also the synthesis of PhiA. A
plausible hypothesis would suggest that an increased synthesis of PhiA might
protect the fungus from uptake of bafilomycin. To test this, we treated the phiA
mutant with bafilomycin and concanamycin. However, no signs of a drastic
increase in sensitivity could be observed.29
Immunohistochemistry
Since it was clear that PhiA had no protective role against the antibiotics, but
rather was involved in sporulation, we decided to raise polyclonal antibodies
against PhiA in order to study its localisation. Using both enzymatic and
fluorescent labelling in the detection protocol, we found that PhiA was mainly
located in the phialides, but also in the adjacent metulae and conidia (Fig. 8). This
may explain the important role of phiA in the development of phialides and
conidia, although the connection with bafilomycin and V-ATPases remains
unclear.
Figure 8. phiA is essential for normal conidiophore development and the encoded protein is
mainly  located in the phialide. (a). Immunohistochemistry of wild-type A. nidulans.  The
polyclonal antibodies bind to the phialides. (b). phiA1 mutant strain. The phialides are not
developed and sporulation is strongly reduced.
(a) (b)30
Discussion
In the present study I have demonstrated the usefulness of mRNA differential
display and proteomics in the search for gene products involved in microbial
interactions. Instead of investigating a direct interaction between bacteria and
filamentous fungi I used the bacterial metabolites, i.e. bafilomycin and
concanamycin. This approach is simpler and eliminates the complexity arising
from the presence of other metabolites that may affect the fungus. However, in an
ecologically relevant situation all competing microbes produce a wide spectrum of
different metabolites involved in the struggle for space and nutrients. Therefore,
strictly speaking, the gene products identified cannot unequivocally be related to a
real fungal-bacterial interaction. On the other hand, the less complex system used
here has the advantage that, in principal, all the gene products identified are
directly connected to the V-ATPase inhibitors, bafilomycin and concanamycin.
In paper I we used RNA-DD and identified five genes with at least ten-fold
change in expression when the fungus was treated with bafilomycin B1. Using 2D-
PAGE (II) we found 20 proteins with changed abundance of at least two-fold. The
differences in numbers and magnitudes of affected genes or proteins reflect the
sensitivities but also limitations of each of the approaches. In RNA-DD, a majority
of the detected DNA fragments turned out not to be differentially expressed, and
were discarded as false positives. There might be some significant errors
associated with the estimated ratios while measuring differential amounts of
transcripts using QRT-PCR. By setting the threshold value relatively high, i.e. at
least a 10-fold change in expression, we ascertained that all five identified genes
indeed were differentially expressed. It is likely that we would have identified
more genes if we had used additional sets of arbitrary primers in RNA-DD. In 2D-
PAGE analyses, it is relatively straightforward to repeat experiments with high
reproducibility. Therefore, it is possible to detect relatively small but significant
changes in protein abundance. Admittedly, false positives are also encountered
when using 2D-PAGE, but, in my experience, occur less frequently than in
differential display. The main disadvantage with 2D-PAGE is that only quite
prominent spots can be identified. However, this is a practical problem that can be
overcome by multiple repeats with pooling of extracted proteins. More proteins
can also be detected by changing the separating conditions, but a subset of the
protein complement may, due to their composition, remain impossible to resolve.
It is clear that all affected genes or proteins cannot have been identified, since
the different results in both approaches indicate that a search has not been
saturated. However, we can draw some conclusions about the response in the
fungus after encountering V-ATPase inhibitors. Treating the fungus with
bafilomycin and concanamycin causes effects at both the mRNA and protein level.
In this study I have identified 25 gene products with changed abundance.
Likewise, I have also shown that the expression of most genes, and the abundances
of most proteins, is not affected. Therefore, in spite of severe morphology and
growth rate effects caused by inhibiting the V-ATPases, it is possible to conclude
that treatments results in only moderate overall effects at the molecular level. This
may not be surprising since the growth and morphology of filamentous fungi can31
be altered drastically if a carbon source is changed, if treated with specific
substances, or if point mutations are induced (Harris et al., 1999; Trinci, 1984).
Unfortunately, most of the identified genes and proteins were previously unknown,
and for most of the known proteins no clear connection could be drawn from gene
product to inhibited V-ATPases.
For only one gene, a connection with inhibited V-ATPases is suggested by
experimental data. This gene, breA, encodes a Zn
2+ binding protein involved in the
uptake of zinc (Segurado et al., 1999). In paper III we have shown that Zn
2+ is
toxic when the V-ATPase is disrupted in A.  nidulans, as in other fungi. This
indicates that the down-regulation of breA may serve to protect the fungus from
toxic Zn
2+. In paper III we also characterized the V-ATPase of A. nidulans by
disrupting vmaA, the gene encoding subunit A. The features of the vmaA1 mutant
confirm previous studies in N. crassa suggesting that the V-ATP is the only target
for the antibiotics (Bowman and Bowman, 2000; Bowman et al., 2000). However,
the phenotype in A. nidulans is more extreme both in terms of morphology and
growth. This may indicate that the V-ATPase or the vacuole plays a somewhat
different role in Aspergillus.  A more plausible explanation is that the observed
phenotype of the vma mutant may reflect the generally slower growth of wild-type
A. nidulans compared to N. crassa.
The most extensively studied of the previously unknown genes is phiA.  In paper
IV we characterized the gene both at the genetic level, by disruption, and at the
protein level, by raising polyclonal antibodies to detect where the protein is
located. The phialides in phiA1 mutant strains cannot develop properly resulting in
a severely reduced asexual sporulation. This peculiar morphology has, to my
knowledge, not been described before. However, numerous abnormal
morphologies of the conidial head have been described. E.g., hyphal like metulae
(Karos and Fischer, 1996) and bristle (Clutterbuck, 1969; Prade and Timberlake,
1993). Most likely, there is no causal connection between the phiA gene and
disrupted V-ATPases. First, since a phiA1  strain does not show increased
sensitivity to the antibiotics, the encoded protein cannot have a protective role. I
propose that the increase in gene expression may be due to the growth arrest
caused by the antibiotics, and that an initiation of conidiophore development takes
place within the fungal pellet. In conclusion, we have identified a new gene that is
probably present in all Euascomycetes. It encodes a protein necessary for normal
asexual development. Since it is present in the cell types that require an intact phiA
gene to develop properly, PhiA probably has a direct functional role in the phialide
and in the conidium.
For the remaining genes and protein we cannot, at this point, draw conclusions
about why their expression or abundance is changed after treatment with
bafilomycin or concanamycin. Their functions may become apparent when
knockouts are created and protein localisation is shown by immunohistochemistry.
The vmaA mutant strain, although very slow growing, may be instrumental in
testing whether the other gene products are directly affected by a disrupted
V-ATPase. This could be approached by creating a double mutant to investigate
whether the vmaA1  mutation can suppress another mutation, or vice versa.
Hopefully, subsequent work will lead to identification of these gene products, or32
their homologues, in a different functional context, and provides clues about their
roles in fungal biology. In combination with such new results, it may be possible
to make use of the information contained within this thesis, to learn more about the
gene product in question, and possibly also to connect the presence of the gene
product with inhibited V-ATPases. This also holds true for the already partially
characterized genes or proteins in this thesis.
Concluding remarks
The main objective of the work described in this thesis was to use techniques from
the expanding area of molecular biology, to study interactions between bacteria
and filamentous fungi, focusing on gene expression in the fungus. More
specifically, I wanted to study changes at the level of gene expression and protein
synthesis in the filamentous fungus A.  nidulans  when its V-ATPases were
inhibited or disrupted. In simple terms, I considered it useful to employ molecular
biology to answer ecological questions.
In the present work I used several different molecular methods; gene cloning and
targeted gene disruption at the DNA level, RNA-DD and QRT-PCR at the RNA
level, and 2D-PAGE and immunohistochemistry at the protein level. The results
obtained can be divided into two categories. Firstly, I showed that both RNA-DD
and 2D-PAGE are useful when screening for gene products, although both
methods have their limitations. In these studies, I identified several new genes and
proteins in A. nidulans that are in some way related to inhibited V-ATPases. I also
report a more detailed characterisation of two genes; vmaA, the gene encoding
subunit A of the V-ATPase in A. nidulans, and phiA, a gene essential for normal
asexual sporulation. Although the description of these two genes is of interest in
several respects, the main contribution of this work – in my own opinion – lies in
the demonstration that several molecular techniques are useful for studies of
interactions between microbes. I hope that this thesis can serve as a guide to other
students or researchers attempting to answer similar questions.33
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